Clinical decision support (CDS) has repeatedly been successful in improving the physicians' drug prescribing for patients with kidney disease. Alerts aimed at drug dosing may address prevention of drug accumulation, but might miss situations when a high-risk patient still receives a nephrotoxin. Alert advancement requires CDS that is focused on the appropriate use of potentially nephrotoxic medications. Unfortunately, the literature is replete with examples of inaccurate or ineffective alerts. However, analyzing these efforts will allow us to advance CDS to be more effective and to better understand how to include early detection of drug-associated acute kidney injury. Attempts have been made to address these limitations of CDS, but there are still opportunities for improvement.

Keywords:
Acute kidney injury, Clinical decision support systems, Drug-related side effects and adverse reactions, Adverse drug events
1.
Twadrous D, Shariff SZ, Haynes RB, Iansavichus AV, Jain AK, Garg AX: Use of clinical decision support systems for kidney-related drug prescribing: a systematic review. Am J Kidney Dis 2011;58:903-914.
2.
Kane-Gill SL, Dasta JF, Schneider PJ, Cook CH: Monitoring abnormal laboratory values as antecedents to drug-induced injury. J Trauma 2005;59:1457-1462.
3.
Forster AJ, Jennings A, Chow C, Leeder C, van Walraven C: A systematic review to evaluate the accuracy of electronic adverse drug event detection. J Am Med Inform Assoc 2012;19:31-38.
4.
Roshanov PS, Fernandes N, Wilczynski JM, Hemens BJ, You JJ, Handler SM, Nieuwlaat R, Souza NM, Beyene J, Van Spall HG, Garg AX, Haynes RB: Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ 2013;346:f657.
5.
Kane-Gill SL, Visweswaran S, Saul MI, Wong AK, Penrod LE, Handler SM: Computerized detection of adverse drug reactions in the medical intensive care unit. Int J Med Inform 2011;80:570-578.
6.
Kirkendall ES, Spires WL, Mottes TA, Schaffzin JK, Barclay C, Goldstein SL: Development and performance of electronic acute kidney injury triggers to identify pediatric patients at risk for nephrotoxic medication-associated harm. Appl Clin Inform 2014;5:313-333.
7.
Roberts GW, Farmer CJ, Cheney PC, Govis SM, Belcher TW, Walsh SA, Adams RJ: Clinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting. J Am Med Inform Assoc 2010;17:308-312.
8.
Handler SM, Cheung PW, Culley CM, Perera S, Kane-Gill SL, Kellum JA, Marcum ZA: Determining the incidence of drug-associated acute kidney injury in nursing home residents. J Am Med Dir Assoc 2014;15:719-724.
9.
Leung AA, Schiff G, Keohane C, Amato M, Simon SR, Cadet B, Coffey M, Kaufman N, Zimlichman E, Seger DL, Yoon C, Bates DW: Impact of vendor computerized physician order entry on patients with renal impairment in community hospitals. J Hosp Med 2013;8:545-552.
10.
Wilson FP, Shashaty M, Testani J, Aqeel I, Borovskiy Y, Ellenberg SS, Feldman HI, Fernandez H, Gitelman Y, Lin J, Negoianu D, Parikh CR, Reese PP, Urbani R, Fuchs B: Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. Lancet 2015;385:1966-1974.
11.
McCoy AB, Waitman LR, Gadd CS, Danciu I, Smith JP, Lewis JB, Schildcrout JS, Peterson JF: A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report. Am J Kidney Dis 2010;56:832-841.
12.
Cartin-Ceba R, Kashiouris M, Plataki M, Kor DJ, Gajic O, Casey ET: Risk factors for development of acute kidney injury in critically ill patients: a systematic review and meta-analysis of observational studies. Crit Care Res Pract 2012;2012:691013.
13.
Cruz DN, Ferrer-Nadal A, Piccinni P, Goldstein SL, Chawla LS, Alessandri E, Belluomo Anello C, Bohannon W, Bove T, Brienza N, Carlini M, Forfori F, Garzotto F, Gramaticopolo S, Iannuzzi M, Montini L, Pelaia P, Ronco C; NEFROINT Investigators: Utilization of small changes in serum creatinine with clinical risk factors to assess the risk of AKI in critically ill adults. Clin J AM Soc Nephrol 2014;9:663-672.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.